Azithromycin, Cefixime, Vitamin C, Vitamin D, and Zinc to Treat Mild Covid-19: A Case Report

  • Khaleel A
  • Shammari H
  • Niazi M
  • et al.
N/ACitations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Background: COVID-19 is a novel acute respiratory disease that first emerged in 2019 and exploded into aworldwide pandemic. Symptoms range from dry cough, fatigue, fever, and pneumonia in mild cases to acuterespiratory distress in critical cases.Case Report: The aim of the present case study is to illustrate the benefits of using select antibiotics anddietary supplements to treat a mild case of COVID-19.Conclusion: A combination of azithromycin, cefixime, vitamin C, vitamin D, and zinc may potentially bebeneficial for the treatment of moderate COVID-19 symptoms.

Cite

CITATION STYLE

APA

Khaleel, A., Shammari, H. A., Niazi, M., Al-Qaisi, T. S., Abutaleb, R., & Tarkhan, A. H. (2021). Azithromycin, Cefixime, Vitamin C, Vitamin D, and Zinc to Treat Mild Covid-19: A Case Report. Indian Journal of Forensic Medicine & Toxicology, 15(3), 2011–2014. https://doi.org/10.37506/ijfmt.v15i3.15610

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free